Surgery Partners, Inc. Common Stock
SGRY Real Time Price USDRecent trades of SGRY by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by SGRY's directors and management
Government lobbying spending instances
-
$22,500 Nov 08, 2024 Issue: Medicare/Medicaid
-
$22,500 Aug 06, 2024 Issue: Medicare/Medicaid
-
$60,000 Jan 20, 2022 Issue: Health Issues
-
$10,000 Jan 20, 2021 Issue: Medicare/Medicaid Health Issues
-
$10,000 Oct 20, 2020 Issue: Medicare/Medicaid Health Issues
-
$110,000 Jul 20, 2020 Issue: Medicare/Medicaid Health Issues Economics/Economic Development
-
$30,000 Apr 20, 2020 Issue: Medicare/Medicaid Health Issues Economics/Economic Development
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of SGRY in WallStreetBets Daily Discussion
Recent insights relating to SGRY
Recent picks made for SGRY stock on CNBC
ETFs with the largest estimated holdings in SGRY
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SGRY Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.